| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q2 2026 | 51 | 164,207 | PRAX, MPLT, STRO, IMMX | 13F-HR | 8/14/2026 | 000184880926000003 |
| Q1 2026 | 49 | 159,645 | PRAX, TARA, STRO, EVMN | 13F-HR | 5/15/2026 | 000184880926000002 |
| Q4 2025 | 46 | 172,378 | PRAX, CDTX, TARA, HRTX | 13F-HR | 2/13/2026 | 000184880926000001 |
| Q3 2025 | 49 | 106,465 | HRTX, CDTX, TARA, RZLT | 13F-HR | 11/14/2025 | 000184880925000008 |
| Q2 2025 | 50 | 101,235 | HRTX, VRNA, JSPR, TARA | 13F-HR | 8/14/2025 | 000184880925000005 |
| Q1 2025 | 47 | 97,207 | HRTX, SLRN, SWTX, TARA | 13F-HR | 5/15/2025 | 000093855225000003 |
| Q4 2024 | 45 | 115,881 | JSPR, PRAX, HRTX, TRML | 13F-HR | 2/14/2025 | 000184880925000001 |
| Q3 2024 | 18 | 106,938 | JSPR, PRAX, XBI calls, HRTX | 13F-HR | 11/14/2024 | 000184880924000011 |
| Q2 2024 | 17 | 174,552 | ALIM, JSPR, HRTX, PRAX | 13F-HR | 8/14/2024 | 000184880924000007 |
| Q1 2024 | 21 | 220,210 | ALIM, JASPER THERAPEUTICS INC, PRAX, IWM puts | 13F-HR | 5/14/2024 | 000184880924000006 |
| Q4 2023 | 20 | 171,327 | ALIM, IWM puts, HRTX, ADMA | 13F-HR | 2/14/2024 | 000184880924000005 |
| Q3 2023 | 29 | 123,989 | ALIM, PRAX, JSPR, HRTX | 13F-HR | 11/13/2023 | 000184880923000004 |
| Q2 2023 | 31 | 107,698 | JSPR, ADMA, LNTH, TELA | 13F-HR | 8/11/2023 | 000184880923000003 |
| Q1 2023 | 31 | 117,314 | JSPR, ADMA, LNTH, IMCR | 13F-HR | 5/15/2023 | 000184880923000002 |
| Q4 2022 | 28 | 113,197 | SPY puts, ADMA, IMCR, TELA | 13F-HR | 2/13/2023 | 000184880923000001 |
| Q3 2022 | 24 | 100,819 | FEZ puts, LNTH, IMCR, ADMA | 13F-HR | 11/14/2022 | 000184880922000008 |
| Q2 2022 | 24 | 98,582 | RDUS, LNTH, ADMA, IMCR | 13F-HR | 8/15/2022 | 000184880922000006 |
| Q1 2022 | 23 | 107,761 | LNTH, RDUS, ADMA, JSPR | 13F-HR | 5/16/2022 | 000184880922000004 |
| Q4 2021 | 27 | 128,852 | JSPR, LNTH, SNCE, IMCR | 13F-HR | 2/14/2022 | 000184880922000002 |
Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each security where the latest filing since 12/18/2024 is a 13D, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Edesa Biotech, Inc.
13D/A
EDSA · 27966L306
|
10.0% |
8/25/2026
Event 8/21/2026
|
|||
| Velan Capital Master Fund LP | 8.0% | ||||
| Velan Horizon Fund LP | 0.2% | ||||
| Velan Capital Opportunity Fund II LLC | 1.9% | ||||
| Velan Horizon GP LLC | 0.2% | ||||
| Velan Capital Holdings LLC | 9.8% | ||||
| Velan Capital Investment Management LP | 10.0% | ||||
| Velan Capital Management LLC | 10.0% | ||||
| Morgan Adam | 10.0% | ||||
| Venkataraman Balaji | 10.0% | ||||
2 other securities where the latest filing is a 13G, the newest filed 8/17/2026. View all